Centessa Pharmaceuticals plc (CNTA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CNTA currently has 154M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 37.55% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 05, 2026 |
10-Q filing | 153.5M shares outstanding |
150M | 0 |
| Mar 31, 2026 |
10-K filing | 154.6M shares outstanding |
150M | 0 |
| Aug 12, 2025 |
10-Q filing | 133.7M shares outstanding |
130M | 0 |
| May 14, 2025 |
10-Q filing | 133.0M shares outstanding |
130M | 0 |
| Mar 24, 2025 |
10-K filing | 133.2M shares outstanding |
130M | 0 |
| Nov 12, 2024 |
10-Q filing | 131.8M shares outstanding |
130M | 0 |
| Aug 13, 2024 |
10-Q filing | 109.5M shares outstanding |
110M | 0 |
| May 13, 2024 |
10-Q filing | 113.0M shares outstanding |
110M | 0 |
| Mar 28, 2024 |
10-K filing | 96.2M shares outstanding |
96M | 0 |
| Nov 13, 2023 |
10-Q filing | 96.6M shares outstanding |
97M | 0 |
| Aug 14, 2023 |
10-Q filing | 95.2M shares outstanding |
95M | 0 |
| May 12, 2023 |
10-Q filing | 94.9M shares outstanding |
95M | 0 |
| Mar 30, 2023 |
10-K filing | 93.4M shares outstanding |
93M | 0 |
| Nov 10, 2022 |
10-Q filing | 94.3M shares outstanding |
94M | 0 |
| Aug 10, 2022 |
10-Q filing | 94.1M shares outstanding |
94M | 0 |
| Jul 01, 2022 |
S-3 filing: The company intends to offer and sell up to $350,000,000 in the aggregate of our ordinary shares, each of which may be represented by one American Depositary Share; senior or subordinated debt securities; warrants to purchase any securities that may be sold under this prospectus; units or any combination of these securities as described in this prospectus. |
91M | 0 |
| May 16, 2022 |
10-Q filing | 90.5M shares outstanding |
91M | 0 |
| Mar 30, 2022 |
10-K filing | 94.0M shares outstanding |
94M | 0 |
| Nov 15, 2021 |
10-Q filing | 89.9M shares outstanding |
90M | 0 |
| Aug 16, 2021 |
10-Q filing | 89.9M shares outstanding |
90M | 0 |